Developed and manufactured by nanoPET Pharma GmbH, Viscover™ is the first comprehensive portfolio of dedicated high-quality imaging agents for preclinical studies. The product portfolio was launched in 2010 and addresses the principal imaging modalities: Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound (US) and Optical Imaging (OI).
nanoPET Pharma GmbH is a biopharmaceutical company that specializes on the R&D, production and marketing of innovative drug substances for diagnostic imaging. Our customers benefit from the long-standing industry expertise our team has attained in the pharmaceutical development of clinical contrast agents. Nanotechnology is a key element of our business allowing us to offer you materials with unique features.
nanoPET's 1000 m2 research and production site is located in Berlin, Germany, in close vicinity to the Charité (Campus Mitte) – one of Europe’s leading university hospitals.